Kennedy Capital Management »

Axsome Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.1M 39k 182.64
2025-09-30 $4.7M 39k 121.45
2025-06-30 $2.9M 28k 104.39
2025-03-31 $679k 5.8k 116.63
2024-12-31 $3.2M 38k 84.61
2024-09-30 $1.7M 19k 89.87
2024-06-30 $1.7M 21k 80.50
2024-03-31 $1.6M 20k 79.80
2023-12-31 $1.1M 13k 79.59
2023-09-30 $845k 12k 69.89
2023-06-30 $700k 9.7k 71.86